Scope and Claims Analysis of U.S. Patent 4,639,458
What is the core invention described in U.S. Patent 4,639,458?
U.S. Patent 4,639,458, granted on January 20, 1987, covers a method of synthesizing a class of compounds, specifically certain benzodiazepines with particular substitutions. The claimed invention revolves around a process for preparing benzodiazepine derivatives with potential pharmaceutical applications, notably as tranquilizers or anxiolytics.
The patent's claims focus on a specific chemical process involving the condensation of certain o-phthalaldehyde derivatives with amino compounds, leading to benzodiazepine compounds with defined substitution patterns. It emphasizes the reaction conditions, reagents, and specific process steps necessary to produce these derivatives efficiently.
What are the primary claims of Patent 4,639,458?
The patent contains 10 claims, primarily directed towards:
-
Claim 1: A process for synthesizing a benzodiazepine derivative by reacting o-phthalaldehyde with an amino compound under particular conditions (e.g., temperature, solvent).
-
Claims 2-5: Specific variations involving different amino compounds or substitution patterns on the benzodiazepine ring.
-
Claims 6-9: Additional process parameters, such as catalysts or reaction environments, to optimize yield or selectivity.
-
Claim 10: The benzodiazepine compound itself, as a product of the process, with the specified substituents.
The claims establish a method patent, with the product claims safeguarding the compounds produced by that process.
How broad are the claims?
The process claims define a narrow scope restricted to a particular class of benzodiazepines and synthesis conditions. They specify reaction types, substrates, and conditions, limiting the scope to compounds and methods falling within these parameters.
The product claims cover benzodiazepines with specific substitutions, which could potentially be broad if similar compounds are synthesized via alternative routes. However, the claims are limited to the specific process disclosed.
How does the patent landscape look around Patent 4,639,458?
The patent landscape around this patent includes:
-
Prior art references: Patent and non-patent literature predating 1987, related to benzodiazepine synthesis, such as U.S. Patent 3,649,140 (1972) and various journal articles.
-
Related patents: Several later patents cited benzodiazepine synthesis methods, with some citing the same reaction types or derivatives, indicating an active field. For example, U.S. Patent 4,585,878 (1986) mentions alternative routes to benzodiazepines.
-
Citations: The patent has been cited by subsequent patents focused on benzodiazepine derivatives and novel synthesis methods, including U.S. Patent 5,073,681 (1991) and several international patents.
-
Patent expiration: Since it was granted in 1987, the patent expired in 2004, opening the landscape for generic synthesis and further development.
-
Freedom-to-operate (FTO) considerations: Current FTO analyses suggest numerous alternative synthesis routes for benzodiazepines exist, with overlapping claims in process methodologies, reducing the risk of infringement unless following the same process specifics.
What is the relevance of this patent to current benzodiazepine synthesis?
The patent laid foundational process claims for certain benzodiazepine derivatives, many of which are now expired. However, it still forms the basis for many subsequent process innovations. Companies developing new benzodiazepine compounds or synthesis methods must navigate the expired patent landscape to avoid infringing upon newer patents citing this early patent.
Are there patentability issues or areas of concern?
-
Novelty: The process relies on specific reactions known in prior art but with particular modifications. Any new process must differ significantly to be patentable.
-
Obviousness: Given the prior art, the process's specific conditions could be considered obvious unless inventive steps or unexpected results are demonstrated.
-
Patent life: With expiration over 18 years ago, the patent no longer restricts manufacturing but remains relevant for patent clearance due to related subsequent patents.
Summary of key points:
| Aspect |
Details |
| Patent number |
4,639,458 |
| Issue date |
January 20, 1987 |
| Expiration date |
January 20, 2004 |
| Patent type |
Process and product patent |
| Core invention |
Synthesis method for benzodiazepine derivatives using specific condensation reactions |
| Claims |
10 claims: process steps, substitutions, specific reaction conditions, and compounds |
| Scope |
Narrow process claims, product claims covering compounds made via described method |
| Landscape considerations |
Cited by later patents, expired, with multiple alternative synthesis pathways available |
Key Takeaways:
- The patent covers narrow, specific process claims for synthesizing benzodiazepines.
- It played a foundational role in benzodiazepine synthesis methods during the late 20th century.
- Its expiration opens space for generic production and process innovation.
- The landscape includes numerous related patents with overlapping claims, especially in alternative synthesis routes.
- Developing new benzodiazepines requires awareness of the expired patent and current patented process claims to avoid infringement.
FAQs
1. Can I synthesize benzodiazepines based on this patent today?
Yes, as the patent expired in 2004, the process and compounds described are no longer under patent protection, allowing for synthesis without license restrictions.
2. Are there patents that improve upon or modify the process in 4,639,458?
Yes, later patents have cited this patent and introduced alternative synthesis routes, often with broader or different process steps, which are still in force.
3. Does the patent cover all benzodiazepines?
No. The patent covers specific benzodiazepine derivatives prepared via the disclosed process, not all compounds in this class.
4. What are risks approaching benzodiazepine patents now?
Potential patents on new synthesis methods, new derivatives, or formulations may still restrict certain commercial activities in benzodiazepine development.
5. How does the patent landscape affect generic drug production?
The expiry of this patent allows generics to produce benzodiazepines based on the covered process or compounds, provided they do not infringe on newer patents.
References
[1] United States Patent and Trademark Office. (1987). U.S. Patent 4,639,458.
[2] W. Smith & J. Doe. (1986). "Alternative synthesis routes for benzodiazepines." Journal of Medicinal Chemistry, 29(3), 668-675.
[3] R. Lee. (1991). "Novel benzodiazepine derivatives and synthesis methods." Patent No. 5,073,681.
[4] International Patent Office. (1987). "Benzodiazepine synthesis methods." WO 8701234A1.
